Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy

IMPORTANCE: Patients with advanced soft-tissue sarcomas (STS) have a median overall survival of less than 18 months. Identification of molecular abnormalities for which targeted therapies are available or can be developed is critical for improving patient outcomes. OBJECTIVE: To characterize targeta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Lucchesi, Carlo, Khalifa, Emmanuel, Laizet, Yec’han, Soubeyran, Isabelle, Mathoulin-Pelissier, Simone, Chomienne, Christine, Italiano, Antoine
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2018
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6233783/
https://ncbi.nlm.nih.gov/pubmed/29801054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.0723
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados